Designing Growth Strategies is in our DNA

Glioblastoma Drugs Market Size, Share & Industry Analysis, By Drug (Temozolomide, Bevacizumab, Carmustine, Lomustine, Procarbazine, and Others), By Drug Class (Alkylating Agents, VEGF/Angiogenesis Inhibitors, Nitrosoureas, Platinum Compounds, Topoisomerase Inhibitors, and Others), By Age Group (Pediatric and Adults), By Type (Branded and Generic), By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Others), and Regional Forecast, 2026-2034

Last Updated :July 17, 2026 | Format:PDF | Report ID: 116045

 

Request a Free Sample

man icon
Mail icon
Mail icon
What's included in this sample
Market segmentation:

Detailed and granular segments, regions and countries covered

Scope of research:

Comprehensive quantitative data and qualitative insights

Report structure:

Representation of data and insights in the report

Key findings:

Market Estimates, Growth Rate, Largest Region and Segment

Index:

Overview of data and insights in each chapter

Research Methodology:

Summary of research processes adopted

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
  • 2021-2034
  • 2025
  • 2021-2024
  • 190